Home > Insider Trading > Filing (0000919574-15-008758)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1293310	Kalobios Pharmaceuticals Inc	KBIO	Pharmaceutical Preparations (2834)	770557236

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1658549	Anthion Partners Ii Llc	379 West Broadway New York NY 10012		No	No	Yes	No
1658843	David Moradi	379 West Broadway New York NY 10012		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-12-16	3,410	$29.32	178,210	No	4	P	Direct
Common Stock	Acquisiton	2015-12-16	3,410	$29.32	178,210	No	4	P	Indirect	Through Anthion Partners II LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	Through Anthion Partners II LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	400,000	Direct

Footnotes

On December 16, 2015, in connection with a private placement of the Issuer's securities that was announced and priced on December 3, 2015, Anthion Partners II LLC, on behalf of David Moradi, the Managing Member of Anthion Partners II LLC, acquired 3,410 shares of the Issuer's common stock, par value $0.001 per share, at a purchase price of $29.32 per share (which was the announced price for the private placement). The aggregate purchase price paid by Anthion Partners II LLC, on behalf of David Moradi, in the transaction was $99,981.20.
The securities reported herein are owned directly by Anthion Partners II LLC and indirectly by David Moradi, the Managing Member of Anthion Partners II LLC. Both Anthion Partners II LLC and David Moradi are members of a "group" (with other persons) for purposes of Section 13(d) of the Securities Exchange Act of 1934. There is no voting or ownership agreement amongst the group members and the other
On December 10, 2015, 200,000 shares were transferred from Anthion Partners II LLC's account to David Moradi's account and are now directly owned by David Moradi. On December 16, 2015, 200,000 additional shares were transferred from Anthion Partners II LLC's account to David Moradi's account and are now directly owned by David Moradi.